São PauloNone of 38 post-treatment patients tested positive.
The blood test tracks viral DNA fragments from dying tumor cells, a check clinics in Brazil cannot run with imaging or biopsy.
Researchers halted randomization; median diagnosis-to-treatment delay ran 87 days.
Sources: Nature